Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Two Day Course: Signal Detection and Regulatory Expectations (London, United Kingdom - November 9th-10th, 2017) - Research and Markets

Research and Markets
Posted on: 10 Oct 17

The "Signal Detection and Regulatory Expectations" conference has been added to Research and Markets' offering.

This course will be of interest to those working in drug safety/pharmacovigilance as well as Regulatory personnel responsible for amending the labelling for products and for the production of the CCSI/DCSI.

Featuring signal evaluation for both innovator and generic products under the newly revised Module IX Signal Management and quantitative assessments.

Increasingly the most common critical findings in Regulatory Inspections are being given for signal detection and management - so the need to identify potential signals and risks in patients has never been greater. The protection of patients through robust and clear methodologies for signal detection amidst the ever increasing regulations requires that Companies need to have trained and competent staff to perform such activities.

This course will provide a detailed overview of all aspects of safety reviews and signal detection within a Company and will cover signal evaluation for both innovator and generic products under the newly revised Module IX Signal Management and quantitative assessments.

Benefits in attending

  • Clarify the EU regulatory requirements for signal detection
  • Understanding the new frequency requirements for safety review
  • How to use the Eudravigilance quantitative signal tool
  • Understand the safety review cycle and the safety review meeting and process
  • Discuss safety communication - the CCSI/SCSI and labelling
  • Gain a better understanding of risk benefit analysis - benefit-risk assessments and benefit-risk outcomes


Day one

09.30 An introduction to safety signals
10.15 The regulatory requirements for signal detection - Module IX
11.15 Refreshments
11.35 The signal review cycle
12.15 Causality and signal detection
13.00 Lunch
14.00 The safety review meeting and process
15.30 Refreshments
15.45 Safety communication

Day two

09.00 Quantitative signal analysis
10.15 Quantitative and qualitative signal detection
11.15 Refreshments
11.35 Signals and their discussion
12.45 Lunch
13.45 Risk benefit analysis
15.00 Refreshments
15.15 Safety assessments life cycle
16.30 Close of course

For more information about this conference visit

View source version on

Business Wire

Last updated on: 10/10/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.